Traws Pharma Q1 EPS $(0.24) Up From $(0.28) YoY, Sales $56.00K, Same YoY
Portfolio Pulse from Benzinga Newsdesk
Traws Pharma (NASDAQ:TRAW) reported a Q1 EPS of $(0.24), an improvement from $(0.28) YoY, with sales remaining flat at $56.00K.
May 16, 2024 | 1:32 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Traws Pharma reported a Q1 EPS of $(0.24), an improvement from $(0.28) YoY, with sales remaining flat at $56.00K.
The improvement in EPS is a positive sign, but the flat sales indicate no growth in revenue. This mixed result is likely to have a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100